Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Pharma
Vaccines
Asia
Cell & Gene Therapy
Drug Delivery
Executives
Manufacturing
Facilities
Recalls
Warning Letters
Marketing
Special Reports
Fierce 50
Special Report
Awards Gala
Resources
Podcasts
Fierce Events
Industry Events
Webinars
Whitepapers
Survey
Events
Subscribe
Subscribe
Pharma
Vaccines
Asia
Cell & Gene Therapy
Drug Delivery
Executives
Manufacturing
Facilities
Recalls
Warning Letters
Marketing
Special Reports
Fierce 50
Special Report
Awards Gala
Resources
Podcasts
Fierce Events
Industry Events
Webinars
Whitepapers
Survey
Events
Subscribe
Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Vascepa
Pharma
Amarin, after stock crash and layoffs, revives patent lawsuit
Amarin is getting a fresh shot to challenge Hikma Pharmaceuticals’ generic version of its fish-oil-derived heart med in the lower courts.
Fraiser Kansteiner
Jun 26, 2024 1:01pm
Amarin's CEO resigns, leaving former interim chief to take over
Jun 4, 2024 11:19am
Teva, like Hikma, accuses Amarin of hoarding Vascepa ingredient
Mar 29, 2024 1:10pm
Amarin axes 120 of its 385 employees, hires new CEO Patrick Holt
Jul 19, 2023 10:45am
After Amarin's clash with Sarissa, CEO Karim Mikhail hits exit
Mar 31, 2023 11:14am
With 7 board resignations, Sarissa strengthens control of Amarin
Mar 7, 2023 10:30am
